Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semi-automatic mask guidance enhances 3D tumor segmentation in medical imaging.

Communications medicine·2026
Same author

Meta-encoder: a unified integration framework for multiple pathological foundation models in cancer detection.

Nature communications·2026
Same author

Integrative genomic profiling of iron homeostasis predicts clinical outcomes and identifies HAMP/hepcidin as a therapeutic target in colorectal cancer.

Cell & bioscience·2026
Same author

Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1.

NPJ precision oncology·2025
Same author

Single-cell disentangled representations for perturbation modeling and treatment effect estimation.

bioRxiv : the preprint server for biology·2025
Same author

Modelling the dynamics of SARS-CoV-2 during the first 14 days of infection.

Epidemics·2025

Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

832

Single-cell biclustering for cell-specific transcriptomic perturbation detection in AD progression.

Yuqiao Gong1, Jingsi Xu1, Maoying Wu1

  • 1Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dongchuan Road, Minhang District, Shanghai 200240, China.

Cell Reports Methods
|March 30, 2024
PubMed
Summary

We developed single-cell Bayesian biclustering (scBC) to find gene network biomarkers in Alzheimer's disease (AD) data. This method reveals how gene modules change in specific cells during AD progression.

Keywords:
Alzheimer’s diseaseCP: systems biologyFunctional gene modulesbiclusteringscBCscRNA-seq

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

Related Experiment Videos

Last Updated: Jun 29, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

832
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

Area of Science:

  • Genomics
  • Computational Biology
  • Neuroscience

Background:

  • Alzheimer's disease (AD) pathogenesis involves complex, cell-specific gene regulatory alterations.
  • Understanding these changes requires advanced computational tools for single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq) data.

Purpose of the Study:

  • To introduce single-cell Bayesian biclustering (scBC), a novel framework for identifying cell-specific gene network biomarkers.
  • To analyze perturbations in functional gene modules at the single-cell level within AD datasets.
  • To address common challenges in single-cell data analysis, such as batch effects and dropout events.

Main Methods:

  • Developed the scBC framework utilizing Bayesian biclustering for gene network analysis.
  • Applied scBC to Alzheimer's disease snRNA-seq data to identify perturbed gene modules.
  • Incorporated prior biological knowledge to enhance interpretability.
  • Evaluated scBC performance against state-of-the-art biclustering methods using simulated and real-world datasets.

Main Results:

  • scBC successfully identified cell-specific gene network biomarkers in AD data.
  • The framework revealed perturbations within gene modules across distinct cell populations during AD progression.
  • scBC demonstrated robustness in handling batch effects and dropout events inherent in single-cell data.
  • Comparative analyses confirmed the precision and reliability of scBC over existing methods.

Conclusions:

  • scBC is a powerful tool for dissecting complex gene regulatory mechanisms in polygenic diseases like Alzheimer's.
  • The framework enhances the biological interpretability of single-cell omics data.
  • scBC offers a robust approach for unraveling intricate gene coexpression patterns in disease pathogenesis.